---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-023195"
form_type: "8-K"
ticker: "SNYR"
cik: "0001562733"
company_name: "Synergy CHC Corp."
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:14:51.296914+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Gravity Pharma terminates $2.9M brand license agreement ab initio for Synergy CHC

## Summary
- Gravity Pharma terminated Brand License Agreement ab initio for FOCUSfactor and Flat Tummy Co. products in UAE & Turkey.
- Agreement provided exclusive license for $2.9M aggregate fee previously recognized as revenue by Synergy CHC.
- Company continues pursuing registration and marketing of licensed IP in the Territory.

## SEC filing metadata
- accession: 0001213900-26-023195
- form_type: 8-K
- ticker: SNYR
- cik: 0001562733
- company_name: Synergy CHC Corp.
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1562733/000121390026023195/0001213900-26-023195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1562733/000121390026023195/ea0279861-8k_synergy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-023195
- JSON: https://secwatch.observer/filing/0001213900-26-023195.json
- Plain text: https://secwatch.observer/filing/0001213900-26-023195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.